Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Academia + Industry
Ideas + Impact
Discovery + Partnerships
Collaboration + Commercialisation
Research + Translation

What we are doing

Staff profiles

Our team

150
Has over 150 years of combined biotech/pharma industry experience

35
Has been directly involved in over 35 Investigational New Drug applications (INDs)

70
Are responsible for 70 therapeutics currently in the clinic

$2.1B
Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate Director the Hon John Brumby will be presenting at the Eradicate Cancer 2020 conference in March to discuss the local & global biotech opportunities in immunotherapy research. The meeting brings together world leaders in the field. More info via http://bit.ly/2usDitu

Prof Gail Risbridger will co-head a key part of the new @arc_gov_au Training Centre for Cell and Tissues Engineering Technologies at Monash, supporting research for new treatments and better outcomes for patients https://bit.ly/2sEJwWm

Prof Elizabeth Vincan and her work on decoding cancer cell communication featured on Eavesdrop on Experts podcast. https://pursuit.unimelb.edu.au/podcasts/decoding-cancer-cell-communication
@OrganoidsAreUs @UniMelbMDHS @TheRMH

AusBiotech seeks industry’s views and policy priorities https://biotechdispatch.com.au/news/ausbiotech-seeks-industrys-views-and-policy-priorities